nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—Abdominal distress—Metformin—metabolic syndrome X	0.0494	0.207	CcSEcCtD
Dipyridamole—PDE3B—brown adipose tissue—metabolic syndrome X	0.038	0.11	CbGeAlD
Dipyridamole—ADA—brown adipose tissue—metabolic syndrome X	0.0288	0.0836	CbGeAlD
Dipyridamole—PDE5A—penis—metabolic syndrome X	0.0227	0.0659	CbGeAlD
Dipyridamole—PDE3A—penis—metabolic syndrome X	0.0221	0.0641	CbGeAlD
Dipyridamole—Emotional distress—Metformin—metabolic syndrome X	0.0157	0.0658	CcSEcCtD
Dipyridamole—Epigastric discomfort—Metformin—metabolic syndrome X	0.0127	0.0532	CcSEcCtD
Dipyridamole—PDE1C—cardiovascular system—metabolic syndrome X	0.0121	0.035	CbGeAlD
Dipyridamole—PDE5A—artery—metabolic syndrome X	0.0105	0.0305	CbGeAlD
Dipyridamole—PRUNE—adipose tissue—metabolic syndrome X	0.00959	0.0278	CbGeAlD
Dipyridamole—PDE6D—adipose tissue—metabolic syndrome X	0.00926	0.0269	CbGeAlD
Dipyridamole—PDE5A—endothelium—metabolic syndrome X	0.00889	0.0258	CbGeAlD
Dipyridamole—PDE7A—kidney—metabolic syndrome X	0.00838	0.0243	CbGeAlD
Dipyridamole—PDE5A—blood vessel—metabolic syndrome X	0.00819	0.0238	CbGeAlD
Dipyridamole—Rigors—Metformin—metabolic syndrome X	0.00819	0.0343	CcSEcCtD
Dipyridamole—PRUNE—liver—metabolic syndrome X	0.00673	0.0195	CbGeAlD
Dipyridamole—PDE7B—adipose tissue—metabolic syndrome X	0.0066	0.0191	CbGeAlD
Dipyridamole—PDE6D—liver—metabolic syndrome X	0.0065	0.0188	CbGeAlD
Dipyridamole—PDE2A—cardiovascular system—metabolic syndrome X	0.00625	0.0181	CbGeAlD
Dipyridamole—PDE11A—liver—metabolic syndrome X	0.00594	0.0172	CbGeAlD
Dipyridamole—PDE3B—cardiovascular system—metabolic syndrome X	0.00582	0.0169	CbGeAlD
Dipyridamole—PDE6G—liver—metabolic syndrome X	0.00572	0.0166	CbGeAlD
Dipyridamole—Ear pain—Metformin—metabolic syndrome X	0.00569	0.0238	CcSEcCtD
Dipyridamole—PDE2A—adipose tissue—metabolic syndrome X	0.00551	0.016	CbGeAlD
Dipyridamole—PDE10A—adipose tissue—metabolic syndrome X	0.00551	0.016	CbGeAlD
Dipyridamole—PDE1B—adipose tissue—metabolic syndrome X	0.00546	0.0158	CbGeAlD
Dipyridamole—PDE8B—adipose tissue—metabolic syndrome X	0.00526	0.0152	CbGeAlD
Dipyridamole—PDE1A—cardiovascular system—metabolic syndrome X	0.00519	0.015	CbGeAlD
Dipyridamole—PDE3B—adipose tissue—metabolic syndrome X	0.00513	0.0149	CbGeAlD
Dipyridamole—PDE1A—kidney—metabolic syndrome X	0.00508	0.0147	CbGeAlD
Dipyridamole—Migraine—Metformin—metabolic syndrome X	0.00478	0.02	CcSEcCtD
Dipyridamole—PDE8A—adipose tissue—metabolic syndrome X	0.00473	0.0137	CbGeAlD
Dipyridamole—PDE7B—liver—metabolic syndrome X	0.00463	0.0134	CbGeAlD
Dipyridamole—PDE1A—adipose tissue—metabolic syndrome X	0.00458	0.0133	CbGeAlD
Dipyridamole—Abdominal pain upper—Metformin—metabolic syndrome X	0.00443	0.0186	CcSEcCtD
Dipyridamole—ADA—cardiovascular system—metabolic syndrome X	0.00441	0.0128	CbGeAlD
Dipyridamole—Cramp muscle—Metformin—metabolic syndrome X	0.00437	0.0183	CcSEcCtD
Dipyridamole—Angina pectoris—Metformin—metabolic syndrome X	0.00409	0.0171	CcSEcCtD
Dipyridamole—Sweating increased—Metformin—metabolic syndrome X	0.00409	0.0171	CcSEcCtD
Dipyridamole—Abdominal discomfort—Metformin—metabolic syndrome X	0.00402	0.0168	CcSEcCtD
Dipyridamole—ADA—adipose tissue—metabolic syndrome X	0.00389	0.0113	CbGeAlD
Dipyridamole—PDE2A—liver—metabolic syndrome X	0.00386	0.0112	CbGeAlD
Dipyridamole—PDE4A—adipose tissue—metabolic syndrome X	0.00379	0.011	CbGeAlD
Dipyridamole—PDE8B—liver—metabolic syndrome X	0.00369	0.0107	CbGeAlD
Dipyridamole—PDE5A—cardiovascular system—metabolic syndrome X	0.00366	0.0106	CbGeAlD
Dipyridamole—PDE3B—liver—metabolic syndrome X	0.0036	0.0104	CbGeAlD
Dipyridamole—PDE3A—cardiovascular system—metabolic syndrome X	0.00356	0.0103	CbGeAlD
Dipyridamole—Bradycardia—Metformin—metabolic syndrome X	0.00342	0.0143	CcSEcCtD
Dipyridamole—Rhinitis—Metformin—metabolic syndrome X	0.00337	0.0141	CcSEcCtD
Dipyridamole—Hepatitis—Metformin—metabolic syndrome X	0.00336	0.0141	CcSEcCtD
Dipyridamole—Hypoaesthesia—Metformin—metabolic syndrome X	0.00334	0.014	CcSEcCtD
Dipyridamole—PDE8A—liver—metabolic syndrome X	0.00332	0.00962	CbGeAlD
Dipyridamole—PDE5A—adipose tissue—metabolic syndrome X	0.00322	0.00935	CbGeAlD
Dipyridamole—PDE1A—liver—metabolic syndrome X	0.00321	0.00931	CbGeAlD
Dipyridamole—PDE3A—adipose tissue—metabolic syndrome X	0.00314	0.00909	CbGeAlD
Dipyridamole—Cardiac disorder—Metformin—metabolic syndrome X	0.00312	0.013	CcSEcCtD
Dipyridamole—Flushing—Metformin—metabolic syndrome X	0.00312	0.013	CcSEcCtD
Dipyridamole—SLC29A1—cardiovascular system—metabolic syndrome X	0.00307	0.0089	CbGeAlD
Dipyridamole—Angiopathy—Metformin—metabolic syndrome X	0.00305	0.0127	CcSEcCtD
Dipyridamole—Immune system disorder—Metformin—metabolic syndrome X	0.00303	0.0127	CcSEcCtD
Dipyridamole—Mediastinal disorder—Metformin—metabolic syndrome X	0.00303	0.0127	CcSEcCtD
Dipyridamole—Chills—Metformin—metabolic syndrome X	0.00301	0.0126	CcSEcCtD
Dipyridamole—SLC29A1—kidney—metabolic syndrome X	0.003	0.00871	CbGeAlD
Dipyridamole—ABCC5—adipose tissue—metabolic syndrome X	0.00295	0.00855	CbGeAlD
Dipyridamole—Flatulence—Metformin—metabolic syndrome X	0.00288	0.0121	CcSEcCtD
Dipyridamole—Dysgeusia—Metformin—metabolic syndrome X	0.00286	0.012	CcSEcCtD
Dipyridamole—Muscle spasms—Metformin—metabolic syndrome X	0.00281	0.0118	CcSEcCtD
Dipyridamole—Tremor—Metformin—metabolic syndrome X	0.00274	0.0115	CcSEcCtD
Dipyridamole—Ill-defined disorder—Metformin—metabolic syndrome X	0.00271	0.0113	CcSEcCtD
Dipyridamole—SLC29A1—adipose tissue—metabolic syndrome X	0.00271	0.00785	CbGeAlD
Dipyridamole—Malaise—Metformin—metabolic syndrome X	0.00264	0.011	CcSEcCtD
Dipyridamole—Syncope—Metformin—metabolic syndrome X	0.00262	0.011	CcSEcCtD
Dipyridamole—Palpitations—Metformin—metabolic syndrome X	0.00258	0.0108	CcSEcCtD
Dipyridamole—Loss of consciousness—Metformin—metabolic syndrome X	0.00257	0.0108	CcSEcCtD
Dipyridamole—Hypertension—Metformin—metabolic syndrome X	0.00252	0.0106	CcSEcCtD
Dipyridamole—Chest pain—Metformin—metabolic syndrome X	0.00249	0.0104	CcSEcCtD
Dipyridamole—Myalgia—Metformin—metabolic syndrome X	0.00249	0.0104	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00247	0.0103	CcSEcCtD
Dipyridamole—Discomfort—Metformin—metabolic syndrome X	0.00246	0.0103	CcSEcCtD
Dipyridamole—Oedema—Metformin—metabolic syndrome X	0.00239	0.00998	CcSEcCtD
Dipyridamole—Shock—Metformin—metabolic syndrome X	0.00235	0.00982	CcSEcCtD
Dipyridamole—Nervous system disorder—Metformin—metabolic syndrome X	0.00234	0.00979	CcSEcCtD
Dipyridamole—Thrombocytopenia—Metformin—metabolic syndrome X	0.00234	0.00977	CcSEcCtD
Dipyridamole—Skin disorder—Metformin—metabolic syndrome X	0.00232	0.0097	CcSEcCtD
Dipyridamole—Hyperhidrosis—Metformin—metabolic syndrome X	0.00231	0.00965	CcSEcCtD
Dipyridamole—ABCC4—kidney—metabolic syndrome X	0.00227	0.00658	CbGeAlD
Dipyridamole—Hypotension—Metformin—metabolic syndrome X	0.00223	0.00933	CcSEcCtD
Dipyridamole—PDE3A—liver—metabolic syndrome X	0.0022	0.00638	CbGeAlD
Dipyridamole—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00217	0.0091	CcSEcCtD
Dipyridamole—Paraesthesia—Metformin—metabolic syndrome X	0.00214	0.00896	CcSEcCtD
Dipyridamole—Dyspnoea—Metformin—metabolic syndrome X	0.00213	0.0089	CcSEcCtD
Dipyridamole—Somnolence—Metformin—metabolic syndrome X	0.00212	0.00887	CcSEcCtD
Dipyridamole—Dyspepsia—Metformin—metabolic syndrome X	0.0021	0.00879	CcSEcCtD
Dipyridamole—ABCC5—liver—metabolic syndrome X	0.00207	0.006	CbGeAlD
Dipyridamole—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00206	0.00862	CcSEcCtD
Dipyridamole—Fatigue—Metformin—metabolic syndrome X	0.00206	0.00861	CcSEcCtD
Dipyridamole—ABCC4—adipose tissue—metabolic syndrome X	0.00204	0.00593	CbGeAlD
Dipyridamole—Feeling abnormal—Metformin—metabolic syndrome X	0.00197	0.00823	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00195	0.00816	CcSEcCtD
Dipyridamole—SLC29A1—liver—metabolic syndrome X	0.0019	0.00551	CbGeAlD
Dipyridamole—Urticaria—Metformin—metabolic syndrome X	0.0019	0.00793	CcSEcCtD
Dipyridamole—Abdominal pain—Metformin—metabolic syndrome X	0.00189	0.00789	CcSEcCtD
Dipyridamole—ABCB1—blood vessel—metabolic syndrome X	0.00181	0.00524	CbGeAlD
Dipyridamole—Asthenia—Metformin—metabolic syndrome X	0.00171	0.00716	CcSEcCtD
Dipyridamole—Pruritus—Metformin—metabolic syndrome X	0.00169	0.00706	CcSEcCtD
Dipyridamole—Diarrhoea—Metformin—metabolic syndrome X	0.00163	0.00683	CcSEcCtD
Dipyridamole—Dizziness—Metformin—metabolic syndrome X	0.00158	0.0066	CcSEcCtD
Dipyridamole—Vomiting—Metformin—metabolic syndrome X	0.00152	0.00635	CcSEcCtD
Dipyridamole—Rash—Metformin—metabolic syndrome X	0.0015	0.00629	CcSEcCtD
Dipyridamole—Dermatitis—Metformin—metabolic syndrome X	0.0015	0.00629	CcSEcCtD
Dipyridamole—Headache—Metformin—metabolic syndrome X	0.00149	0.00625	CcSEcCtD
Dipyridamole—ABCC4—liver—metabolic syndrome X	0.00143	0.00416	CbGeAlD
Dipyridamole—Nausea—Metformin—metabolic syndrome X	0.00142	0.00593	CcSEcCtD
Dipyridamole—ABCB1—cardiovascular system—metabolic syndrome X	0.000807	0.00234	CbGeAlD
Dipyridamole—ABCB1—kidney—metabolic syndrome X	0.000789	0.00229	CbGeAlD
Dipyridamole—ABCB1—adipose tissue—metabolic syndrome X	0.000711	0.00206	CbGeAlD
Dipyridamole—ABCB1—liver—metabolic syndrome X	0.000499	0.00145	CbGeAlD
Dipyridamole—PDE1C—Disease—TGFB1—metabolic syndrome X	6.7e-05	0.000161	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	6.68e-05	0.000161	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—TGFB1—metabolic syndrome X	6.61e-05	0.000159	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—APOE—metabolic syndrome X	6.59e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—LPL—metabolic syndrome X	6.58e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CCL2—metabolic syndrome X	6.57e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.56e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.56e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL5—metabolic syndrome X	6.55e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PLA2G4A—metabolic syndrome X	6.52e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—APOA1—metabolic syndrome X	6.52e-05	0.000157	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—ALB—metabolic syndrome X	6.51e-05	0.000156	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF2—metabolic syndrome X	6.5e-05	0.000156	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL6—metabolic syndrome X	6.46e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL6—metabolic syndrome X	6.46e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IRS1—metabolic syndrome X	6.43e-05	0.000155	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IRS1—metabolic syndrome X	6.43e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—AKT1—metabolic syndrome X	6.41e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—LPL—metabolic syndrome X	6.4e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IRS1—metabolic syndrome X	6.37e-05	0.000153	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PPARA—metabolic syndrome X	6.36e-05	0.000153	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—EPHX2—metabolic syndrome X	6.34e-05	0.000152	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	6.34e-05	0.000152	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—APOB—metabolic syndrome X	6.31e-05	0.000152	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—NOS3—metabolic syndrome X	6.22e-05	0.00015	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AGT—metabolic syndrome X	6.16e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL5—metabolic syndrome X	6.16e-05	0.000148	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—INS—metabolic syndrome X	6.16e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—INS—metabolic syndrome X	6.16e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	6.13e-05	0.000147	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	6.11e-05	0.000147	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TGFB1—metabolic syndrome X	6.11e-05	0.000147	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TGFB1—metabolic syndrome X	6.11e-05	0.000147	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—APOE—metabolic syndrome X	6.04e-05	0.000145	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—LPL—metabolic syndrome X	6.02e-05	0.000145	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AGT—metabolic syndrome X	6.02e-05	0.000145	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—AKT1—metabolic syndrome X	5.99e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—metabolic syndrome X	5.99e-05	0.000144	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—APOA1—metabolic syndrome X	5.97e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—AKT1—metabolic syndrome X	5.96e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—AKT1—metabolic syndrome X	5.96e-05	0.000143	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—G6PC2—metabolic syndrome X	5.96e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.95e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF2—metabolic syndrome X	5.94e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—LEP—metabolic syndrome X	5.89e-05	0.000142	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—APOE—metabolic syndrome X	5.89e-05	0.000142	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IRS1—metabolic syndrome X	5.88e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.85e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—APOA1—metabolic syndrome X	5.83e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APOB—metabolic syndrome X	5.77e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—metabolic syndrome X	5.76e-05	0.000138	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTGS2—metabolic syndrome X	5.69e-05	0.000137	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—SERPINE1—metabolic syndrome X	5.66e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—SERPINE1—metabolic syndrome X	5.66e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AGT—metabolic syndrome X	5.63e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL5—metabolic syndrome X	5.63e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—INS—metabolic syndrome X	5.63e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PLA2G4A—metabolic syndrome X	5.61e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—AKT1—metabolic syndrome X	5.52e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—APOE—metabolic syndrome X	5.52e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—LEP—metabolic syndrome X	5.52e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—LPL—metabolic syndrome X	5.51e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AGT—metabolic syndrome X	5.48e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—metabolic syndrome X	5.47e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—APOA1—metabolic syndrome X	5.46e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—AKT1—metabolic syndrome X	5.45e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TGFB1—metabolic syndrome X	5.45e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—metabolic syndrome X	5.41e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—metabolic syndrome X	5.41e-05	0.00013	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOS3—metabolic syndrome X	5.4e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOS3—metabolic syndrome X	5.4e-05	0.00013	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	5.38e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—LEP—metabolic syndrome X	5.37e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—APOE—metabolic syndrome X	5.37e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—AKT1—metabolic syndrome X	5.31e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—APOA1—metabolic syndrome X	5.31e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IRS1—metabolic syndrome X	5.26e-05	0.000126	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PPARG—metabolic syndrome X	5.26e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—SERPINE1—metabolic syndrome X	5.17e-05	0.000124	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—INS—metabolic syndrome X	5.16e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AGT—metabolic syndrome X	5.15e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—AKT1—metabolic syndrome X	5.13e-05	0.000123	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TGFB1—metabolic syndrome X	5.11e-05	0.000123	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—FABP4—metabolic syndrome X	5.06e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TGFB1—metabolic syndrome X	5.06e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TGFB1—metabolic syndrome X	5.06e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—metabolic syndrome X	5.05e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—LEP—metabolic syndrome X	5.05e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—APOE—metabolic syndrome X	5.05e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—AKT1—metabolic syndrome X	5.05e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—INS—metabolic syndrome X	5.04e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—metabolic syndrome X	5e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—AKT1—metabolic syndrome X	5e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—AKT1—metabolic syndrome X	5e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—APOA1—metabolic syndrome X	4.99e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—metabolic syndrome X	4.98e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCL2—metabolic syndrome X	4.95e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOS3—metabolic syndrome X	4.94e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTGS2—metabolic syndrome X	4.94e-05	0.000119	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTGS2—metabolic syndrome X	4.94e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IRS1—metabolic syndrome X	4.92e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IGF1—metabolic syndrome X	4.87e-05	0.000117	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	4.8e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IRS1—metabolic syndrome X	4.79e-05	0.000115	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ALB—metabolic syndrome X	4.73e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—INS—metabolic syndrome X	4.71e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AGT—metabolic syndrome X	4.71e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TGFB1—metabolic syndrome X	4.69e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—AKT1—metabolic syndrome X	4.69e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—AKT1—metabolic syndrome X	4.66e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCL2—metabolic syndrome X	4.64e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TGFB1—metabolic syndrome X	4.63e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SERPINE1—metabolic syndrome X	4.63e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—LEP—metabolic syndrome X	4.62e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APOE—metabolic syndrome X	4.62e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—AKT1—metabolic syndrome X	4.62e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—metabolic syndrome X	4.6e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—metabolic syndrome X	4.6e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—AKT1—metabolic syndrome X	4.6e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—INS—metabolic syndrome X	4.59e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—metabolic syndrome X	4.58e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APOA1—metabolic syndrome X	4.56e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF1—metabolic syndrome X	4.56e-05	0.00011	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—NOS3—metabolic syndrome X	4.52e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—metabolic syndrome X	4.52e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFB1—metabolic syndrome X	4.51e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL2—metabolic syndrome X	4.51e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IRS1—metabolic syndrome X	4.5e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—metabolic syndrome X	4.49e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF1—metabolic syndrome X	4.44e-05	0.000107	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	4.43e-05	0.000106	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	4.42e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NOS3—metabolic syndrome X	4.42e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SERPINE1—metabolic syndrome X	4.33e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—INS—metabolic syndrome X	4.31e-05	0.000104	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—G6PD—metabolic syndrome X	4.28e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AKT1—metabolic syndrome X	4.25e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AKT1—metabolic syndrome X	4.25e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL2—metabolic syndrome X	4.24e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—AKT1—metabolic syndrome X	4.22e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SERPINE1—metabolic syndrome X	4.21e-05	0.000101	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HDAC3—metabolic syndrome X	4.18e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF1—metabolic syndrome X	4.17e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AKT1—metabolic syndrome X	4.14e-05	9.95e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—metabolic syndrome X	4.14e-05	9.94e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOS3—metabolic syndrome X	4.13e-05	9.94e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	4.13e-05	9.92e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IRS1—metabolic syndrome X	4.12e-05	9.9e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—metabolic syndrome X	4.1e-05	9.86e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LPA—metabolic syndrome X	4.08e-05	9.81e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCKR—metabolic syndrome X	4.08e-05	9.81e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOS3—metabolic syndrome X	4.02e-05	9.66e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SERPINE1—metabolic syndrome X	3.96e-05	9.52e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	3.95e-05	9.5e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—INS—metabolic syndrome X	3.94e-05	9.48e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOA5—metabolic syndrome X	3.91e-05	9.41e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL2—metabolic syndrome X	3.88e-05	9.32e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—metabolic syndrome X	3.81e-05	9.17e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—metabolic syndrome X	3.81e-05	9.17e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF1—metabolic syndrome X	3.81e-05	9.17e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—metabolic syndrome X	3.79e-05	9.1e-05	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—metabolic syndrome X	3.78e-05	9.09e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOS3—metabolic syndrome X	3.78e-05	9.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	3.73e-05	8.97e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—metabolic syndrome X	3.72e-05	8.95e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TRIB3—metabolic syndrome X	3.64e-05	8.74e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SERPINE1—metabolic syndrome X	3.62e-05	8.7e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—metabolic syndrome X	3.57e-05	8.58e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—metabolic syndrome X	3.57e-05	8.58e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—metabolic syndrome X	3.55e-05	8.54e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.54e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—metabolic syndrome X	3.54e-05	8.5e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—metabolic syndrome X	3.52e-05	8.46e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—metabolic syndrome X	3.52e-05	8.46e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	3.5e-05	8.41e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—metabolic syndrome X	3.49e-05	8.38e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—metabolic syndrome X	3.49e-05	8.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOS3—metabolic syndrome X	3.46e-05	8.31e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.45e-05	8.28e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—metabolic syndrome X	3.44e-05	8.26e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—metabolic syndrome X	3.4e-05	8.17e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—metabolic syndrome X	3.39e-05	8.15e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—metabolic syndrome X	3.27e-05	7.85e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NAMPT—metabolic syndrome X	3.26e-05	7.84e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—metabolic syndrome X	3.26e-05	7.84e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LIPC—metabolic syndrome X	3.24e-05	7.79e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCK—metabolic syndrome X	3.24e-05	7.79e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—metabolic syndrome X	3.24e-05	7.79e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOC3—metabolic syndrome X	3.22e-05	7.74e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—metabolic syndrome X	3.22e-05	7.74e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—metabolic syndrome X	3.22e-05	7.73e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—metabolic syndrome X	3.19e-05	7.66e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—metabolic syndrome X	3.14e-05	7.54e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—metabolic syndrome X	3.13e-05	7.52e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CETP—metabolic syndrome X	3.13e-05	7.52e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	3.07e-05	7.38e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SCARB1—metabolic syndrome X	3e-05	7.2e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—metabolic syndrome X	2.96e-05	7.12e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—metabolic syndrome X	2.94e-05	7.07e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—metabolic syndrome X	2.92e-05	7.02e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—metabolic syndrome X	2.92e-05	7.01e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—metabolic syndrome X	2.91e-05	7e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SREBF1—metabolic syndrome X	2.91e-05	6.99e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—metabolic syndrome X	2.86e-05	6.88e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HMGCR—metabolic syndrome X	2.83e-05	6.8e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GOT2—metabolic syndrome X	2.83e-05	6.8e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	2.77e-05	6.67e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—metabolic syndrome X	2.73e-05	6.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—metabolic syndrome X	2.69e-05	6.47e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—metabolic syndrome X	2.69e-05	6.47e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—metabolic syndrome X	2.69e-05	6.47e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—metabolic syndrome X	2.69e-05	6.46e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—metabolic syndrome X	2.67e-05	6.4e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—metabolic syndrome X	2.66e-05	6.39e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ABCA1—metabolic syndrome X	2.52e-05	6.06e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	2.52e-05	6.06e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—metabolic syndrome X	2.5e-05	6.01e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—metabolic syndrome X	2.48e-05	5.96e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—metabolic syndrome X	2.48e-05	5.96e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—metabolic syndrome X	2.46e-05	5.91e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—metabolic syndrome X	2.46e-05	5.91e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GGT1—metabolic syndrome X	2.44e-05	5.87e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GOT1—metabolic syndrome X	2.44e-05	5.87e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—metabolic syndrome X	2.29e-05	5.5e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—metabolic syndrome X	2.27e-05	5.46e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—metabolic syndrome X	2.2e-05	5.29e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—metabolic syndrome X	2.08e-05	5e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOB—metabolic syndrome X	2.07e-05	4.98e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—metabolic syndrome X	2.06e-05	4.95e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—metabolic syndrome X	2.03e-05	4.88e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	2.02e-05	4.85e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—metabolic syndrome X	2e-05	4.82e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LPL—metabolic syndrome X	1.98e-05	4.76e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—metabolic syndrome X	1.9e-05	4.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—metabolic syndrome X	1.88e-05	4.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CD36—metabolic syndrome X	1.88e-05	4.52e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—metabolic syndrome X	1.85e-05	4.44e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.75e-05	4.2e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—metabolic syndrome X	1.74e-05	4.18e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—metabolic syndrome X	1.72e-05	4.14e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AGT—metabolic syndrome X	1.69e-05	4.07e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOE—metabolic syndrome X	1.66e-05	3.99e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.64e-05	3.94e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—metabolic syndrome X	1.59e-05	3.82e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARG—metabolic syndrome X	1.44e-05	3.47e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—INS—metabolic syndrome X	1.42e-05	3.41e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—metabolic syndrome X	1.3e-05	3.12e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NOS3—metabolic syndrome X	1.24e-05	2.99e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—metabolic syndrome X	1.14e-05	2.73e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—metabolic syndrome X	5.71e-06	1.37e-05	CbGpPWpGaD
